320-x-100_uti_gold.jpg" alt="Advertisement">
Dr. Reddy`s Laboratories rises as its arm incorporates wholly-owned subsidiary in Finland
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
Dr. Reddy's Laboratories is currently trading at Rs. 1354.45, up by 13.65 points or 1.02% from its previous closing of Rs. 1340.80 on the BSE.
The scrip opened at Rs. 1349.90 and has touched a high and low of Rs. 1355.00 and Rs. 1336.70 respectively. So far 20166 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 1420.20 on 21-Aug-2024 and a 52 week low of Rs. 1104.69 on 18-Jan-2024.
Last one week high and low of the scrip stood at Rs. 1369.15 and Rs. 1250.10 respectively. The current market cap of the company is Rs. 112897.56 crore.
The promoters holding in the company stood at 26.64%, while Institutions and Non-Institutions held 49.01% and 10.13% respectively.
Dr. Reddy's Laboratories’ wholly-owned subsidiary -- Dr. Reddy’s Laboratories SA, Switzerland, (DRSA) has incorporated a new wholly-owned subsidiary in Finland, named ‘Dr. Reddy's Finland Oy’ on December 20, 2024. Accordingly, Dr. Reddy's Finland Oy is a step-down wholly-owned subsidiary of the company.
Dr. Reddy's Finland Oy's business is healthcare and pharmaceutical products and general marketing, sales and promotion of medical devices and marketing and consulting of these products. The business of the Dr. Reddy's Finland Oy is in line with the main line of business of the company.
Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.
